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Abstract Two hundred and twenty-six children who un-
derwent renal replacement therapy (RRT) from 1992 to
1998 were retrospectively reviewed. The mean age, at
the onset of RRT, was 74±11.7 months and weight was
25.3±9.7 kg. RRT therapies included hemofiltration (HF;
n=106 children for an average of 8.7±2.3 days), hemodi-
alysis (HD; n=61 children for an average of 9.5±1.7
days), and peritoneal dialysis (PD; n=59 children for an
average of 9.6±2.1 days). Factors influencing patient
survival included: (1) low blood pressure (BP) at onset
of RRT (33% survival with low BP, vs 61% with normal
BP, vs 100% with high BP; P<0.05), (2) use of pressors
anytime during RRT (35% survival in those on pressors
vs 89% survival in those not requiring pressors; P<0.01),
(3) diagnosis (primary renal failure with a high likeli-
hood of survival vs secondary renal failure; P<0.05), (4)
RRT modality (40% survival with HF, vs 49% survival
with PD, vs 81% survival with HD; P<0.01 HD vs PD or
HF), and (5) pressor use was significantly higher in chil-
dren on HF (74%) vs HD (33%) or PD (81%; P<0.05
HD vs HF or PD). In conclusion, pressor use has the
greatest prediction of survival, rather than RRT modality.
Patient survival in children with the need for RRT for
ARF is similar to in adults and, as in adults, is best pre-
dicted by the underlying diagnosis and hemodynamic
stability.
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Introduction
The care of a child with multiorgan system failure
(MOSF) and the need for renal replacement therapy
(RRT) has changed dramatically over the last 15 years
[1]. In the 1970s and 1980s, the RRT of choice was (pri-
marily) acute peritoneal dialysis (PD) with some acute
hemodialysis (HD) [2]. In the area of intoxications or in-
born errors of metabolism, HD, if available, was consid-
ered a first-line RRT [3, 4]. Over the last decade improve-
ment in vascular access, pediatric specific equipment, and
improved techniques, as well as understanding in the area
of critical care nephrology, have allowed for improved
care of children with MOSF who need RRT [5–9].
In 1992 the Division of Pediatric Nephrology at the
University of Michigan developed a database to identify
patients requiring RRT at the C.S. Mott Children’s Hos-
pital. Indications for RRT included: (1) primary or sec-
ondary renal failure; (2) inborn errors of metabolism;
and (3) intoxications.
The database allowed compilation of information
such as age, sex, and indication for RRT, type of modali-
ty, access, and patient survival (Table 1). This large se-
ries of children requiring RRT permitted us to delineate
patient survival variables based on the RRT modality as
well as their disease process.
This database is approved by the Institutional Review
Board (IRB) at the University of Michigan.
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Table 1 Demographics of the database
− Age − BP at onset
− Weight − Use of vasopressors
− Diagnosis − Complications
− Indication − Renal recovery
− RRT modality − Function
− Duration − Survival
− Access − Change in modality
Materials and methods
The indications for starting RRT and the type of RRT were based
on the decision of the nephrologist on service at that time. Over
time the general trend has changed from PD to HD and hemofil-
tration (HF). The indications to begin RRT include oliguria, rising
blood urea nitrogen (BUN), hyperkalemia (K >5.5 mEq/dl), pul-
monary edema, and insufficient urine output to allow for medica-
tion infusion and/or nutrition. Previous work by Fleming et al. has
demonstrated that RRT such as HF may allow for greater nutri-
tional delivery when compared with PD [10].
The majority of children were located in one area in the Pediat-
ric Intensive Care Unit (PICU) that housed both medical and sur-
gical patients. A smaller group of children were either in the Car-
diac Intensive Care Unit or the Neonatal Intensive Care Unit.
From 1992 to 1998, a total of 379 children underwent RRT. In-
dications included end stage renal disease (ESRD, N=96), acute
renal failure (ARF, N=226), ARF while on extracorporeal mem-
brane oxygenation (ECMO, N=35), inborn errors of metabolism
(N=11), and intoxications (N=11). This report will focus on the
226 children who underwent RRT for ARF. Of these 226 children,
106 children underwent hemofiltration (HF), 61 underwent hemo-
dialysis (HD), and 59 underwent peritoneal dialysis (PD).
The usual PD prescription included the use of either commer-
cially available or pharmacy made (bicarbonate) PD solution. This
choice was based upon the metabolic acidosis and hepatic function
of the child at the onset of RRT. In children weighing less than 
20 kg a manual PD system (Gesco Pedialyate, San Antonio, TX)
was used,  while in larger children the use of the Pac-Xtra (Baxter,
Deerfield, IL) was utilized. Volumes per pass were 10–15 ml/kg
with glucose concentration, heparin and antibiotics based upon
clinical needs [11].
The usual HD prescription used Baxter 1550 (Deerfield, IL) ma-
chine with appropriate neonatal, pediatric, or adult bloodlines. The
dialysate bath was adjusted only for potassium and the net ultrafil-
tration. The duration and frequency of each treatment was deter-
mined based upon the needs of the child. Dialyzer was based upon
the size of the child but included the use of the HG-100 (COBE,
Lakewood, CO), CA-50–170 series (Baxter Deerfield, IL) and the
CT-110–190 series (Baxter, Deerfield, IL). Blood flow rate was
targeted to 4–5 ml/kg/min [11].
The usual HF prescription utilized either an adapted HF ma-
chine (Gambro AK-10, Lakewood, CO) or the PRISMA (Gambro,
Lakewood, CO). Hemofiltration membrane choice in children
with the adapted system included the Miniplus (Minnetech, Min-
neapolis, MN), HF-400 (Renal Systems, Minneapolis, MN) or the
M-60 (COBE, Lakewood, CO). Blood flow rate was targeted to
4–5 ml/kg/min and replacement fluid in those undergoing CVVH
or dialysate fluid in those undergoing CVVHD was prescribed at
2000 ml/h/1.73 m2. This prescription has been previously ad-
dressed in work by Maxvold et al. looking at urea clearance in
CVVH vs CVVHD [12]. The attending nephrologist made the
choice of CVVH or CVVHD on service at onset of RRT. Replace-
ment fluid, or dialysate fluid, was always a pharmacy-made solu-
tion containing bicarbonate. In those children receiving a phos-
phorus-based solution, a calcium infusion was used and the rate of
infusion was adjusted based upon hourly to every hour analysis of
the ionized calcium [11].
Daily communication occurred between the nephrology and
critical care staff in order to optimize the amount of nutrition and
to avoid excessive potassium or phosphorus delivery by the nutri-
tion. Initially protein delivery was targeted to 1.5 g/kg/day but ad-
justed upwards based upon measurement of energy expenditure
and nitrogen balance [12].
Statistics
Data are presented as means ± SEM. Statistical analysis was per-
formed with the Fisher exact test and statistical significance set at
P<0.05.
Results
The mean age at the time of starting RRT was 74±11.7
months (range: newborn to 216 months), and mean
weight was 25.3±9.7 kg (range: 3.5–83 kg). Fifty-one
percent of these children were male and 32% of the chil-
dren were hypotensive as defined as <5% of normal
blood pressure for age of RRT [13]. Of the 226 children
who underwent therapy for ARF, the primary diagnoses
included bone marrow transplant (BMT; N=26), tumor
lysis syndrome/malignancy (N=17), congenital heart dis-
ease (N=47), cardiac transplant (N=13), hemolytic ure-
mic syndrome (HUS) (N=16), ARF with acute tubular
necrosis (N=46), status postliver transplant (N=22), and
sepsis (N=39; Table 2).
Duration of RRT
Time on RRT therapy for the total 226 children was
8.7±2.3 days on HF, 9.5±1.7 days on HD, and 9.6±2.1
days on PD. No significant difference between time of
therapy among the three modalities was found.
Anticoagulation requirement
The decision to use heparin was based upon the coagula-
tion status of the child at the onset of RRT. Many chil-
dren were coagulopathic due to their underlying cause of
illness. In those children with a pre RRT activated clot-
ting time (ACT) of >150 s, an attempt to treat them with-
out heparin during RRT was made. In total, 51% on HF
underwent heparin-free therapy while 28% on HD un-
derwent heparin-free therapy (P<0.01).
Hemofiltration filter life was similar in those who
were run with heparin (68.5±7.3 h) versus those who
were run heparin “free” (65.9±8.9 h; NS).
Access
One hundred percent of the children on HF had acute
(non-cuffed) access, 59% on HD had acute access, and
53% of PD patients required acute access (P<0.01 for
HF vs HD or PD). The PICU physician placed the acute
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Table 2 Diagnosis (n) and (%) survival by diagnosis in children
on RRT (BMT bone marrow transplant, TLS/Mal tumor lysis syn-
drome/malignancy, CHD congenital heart disease, Ht Tx heart
transplant, HUS hemolytic uremic syndrome, ATN acute tubular
necrosis, Liv Tx liver transplantation)
Diagnosis N Survival Diagnosis N Survival
BMT 26 42% HUS 16 94%
TLS/Mal 17 58% ATN 46 67%
CHD 47 39% Liv Tx 22 17%
Ht Tx 13 67% Sepsis 39 33%
vascular access while the acute PD catheters were placed
by the pediatric nephrologist [14].
Vascular access for HF or HD was preferable in the
right internal jugular but the critical care physician on
service at the time decided placement. The choice of
acute access for HF or HD was either a 7-French dual lu-
men [(Bunchman coaxial or minipuncture) Cook Critical
Care, Bloomington, IN, or Medcomp, Harleysville, PA],
8-French dual lumen (Quinton, Bothell, WA or Arrow
International Inc., Reading, PA) or a 12-French triple lu-
men (Arrow International Inc., Reading, PA).
Cuffed (chronic) access was placed by the surgical
staff in 41% of HD patients and 47% of the PD patients.
The HD access was either an 8-French or 10-French dual
lumen access (Medcomp, Harleysville, PA) while the PD
access was either a single or double cuffed catheter
(Quinton, Bothell, WA).
Vasopressor requirements
Vasopressor use in the PICU was based on the clinical re-
quirements of the child. Of those children undergoing RRT,
74% were on pressors at some point while on HF, 33%
were on pressors at some point of HD, and 81% were on
pressors at some point of PD (P<0.05 HD vs HF or PD).
Evaluation by blood pressure at onset of RRT: 
correlation with survival
A review of BP at commencement of RRT revealed 33%
of the children with hypotension at onset of RRT sur-
vived, 61% with normal blood pressure at onset survived
and 100% of the children with high blood pressure sur-
vived (P<0.01 of high blood pressure vs normal or low).
Blood pressure parameters were defined by the percen-
tiles of <5% (hypotension), >5% – <95% (normal) and
>95% (high) as defined by the Task Force on Blood
Pressure for Children [13].
Survival by vasopressor use
In this ARF population, children who required vasopres-
sor agents at any time had a 35% survival rate while
children who required no use of pressors had a 89% sur-
vival rate (P<0.01; Fig. 1).
Weight at onset of RRT: correlation with survival
The mean weight of survivors was 27.9±3.7 kg vs non-
survivors with 23.7±4.9 kg (NS). When one looked at sur-
vival by RRT and weight there were no differences in the
weight of survivors vs non-survivors in those children un-
dergoing HF or HD. However, there was a significant dif-
ference in children undergoing PD, with those of greater
weight having a more favorable outcome (Fig. 2). Look-
ing at the PD population, in the smaller children, there
was an increase in infants with congenital heart disease. A
trend toward PD occurred in the congenital heart patients
due to surgical bias that at times placed PD catheters in
the operating room prior to notification of nephrology.
Evaluation by gender
Comparison by sex revealed that 63% of females sur-
vived while 45% of males survived (P<0.01).
Survival
The overall survival rate of children with ARF was 54%.
More specifically, the survival rate of children treated
with HF was 40%, with PD 49%, and with HD 81%
(P<0.01 HD vs HF or PD).
Overall survival by diagnosis is noted in Table 2. A
subanalysis of the 226 children with ARF revealed that
children receiving HD had a higher survival rate than
those receiving HF (an example of this can be seen in the
BMT and sepsis population as outlined in Fig. 3). To ex-
plain this difference one needs to look at the vasopressor
used by diagnosis and RRT modality. Upon review of
RRT modality and disease state, patients undergoing HD
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Fig. 1 Survival by analysis of vasopressor use during RRT. There
was a greater survival rate in those children not requiring vaso-
pressors any time during RRT as compared to those requiring
vasopressors during RRT (P<0.01)
Fig. 2 Survival by weight and RRT choice. There was no differ-
ence in survival in analysis by weight of those children on HF or
HD. In those children on PD, there was a significant difference in
weight between survivors and non-survivors (P<0.05)
had much less vasopressor use than those on HF or PD
(an example of this can be seen in the BMT and sepsis
population as outlined in Fig. 4). The reason for less va-
sopressor use was not due to the HD modality but the ra-
tionale of choosing the HD modality. HD was used in
patients who were deemed to have clinical hemodynamic
instability that would subsequently tolerate rapid fluid
shifts that occur with HD. Multivariant analysis identi-
fied the use of vasopressor agent as the greatest indicator
of survival in this population.
Complications
Complication rates during RRT (e.g., hypotension, bleed-
ing, infections) were minimal. Complications related to
access for placement for HD and HF (done by the Critical
Care Staff) were few. There was no evidence of pneumo-
thorax and only one had a hemothorax. Seven cases out of
the 140 (5%) requiring acute access had some bleeding
around the site and 8 out of 140 (6%) had clotted accesses.
Thirty-one acute, non-cuffed, peritoneal dialysis cath-
eters were placed by the pediatric nephrology faculty. No
evidence of perforated viscus or bleeding was noted, and
less than a 5% complication rate of inflow or outflow
problems occurred. These were remedied by the replace-
ment of the catheter in a different position.
No peritonitis occurred in the PD population or “line
infection” in the HF or HD population although all of
these children were on antibiotics at the onset of RRT,
possibly affecting the relative risk of infection.
Discussion
Outcome for children requiring RRT varies throughout
the world [14–18]. Reports to date have compared PD vs
HF or PD vs HD and there was also a recent report by
this group that looked at a retrospective outcome in HD
vs HF [10, 18–20]. The outcome of children requiring
RRT is usually not directly related to the RRT modality,
but rather to the seriousness of the underlying illness of
the patient as defined by vasopressor requirement [21].
This is similar to ARF outcome data in adults, which
identify underlying diagnosis requiring RRT and evi-
dence of MOSF (as measured by APACHE scores) as the
best predictors of survival [22].
The data herein suggest that the requirement for pres-
sors is most predictive of outcome in children. This sug-
gests that those children with MOSF requiring pressors
have a greater risk of not surviving. Rather than suggest
that these patients should not be taken care of, the onus
is on the clinician to learn from this experience and look
for better ways to take care of these children, potentially
prior to the onset of the need for pressors. Data suggest
that early intervention of RRT might affect outcome, and
perhaps RRT as an intervention prior to the need for
pressors may make a difference in this population [23,
24]. Further, mixing and matching RRT modalities may
also improve outcome. This may explain in part what ap-
pears to be an improving survival in the BMT population
compared to historical reports [25].
Other factors influencing outcome are appropriate
dosing of antibiotics, as well as nutritional adequacy.
Nutrition has been shown to affect ARF outcome [26].
Modalities such as HF have been shown to remove nutri-
tional components especially amino acids during ongo-
ing therapy [12, 27]. Therefore, attention to nutrition re-
quirements and assurance that “adequate” nutrition is
given to patients undergoing RRT is important to opti-
mize the nutritional competency for recovery.
The outcome of children requiring RRT requires a co-
operative effort between the PICU and nephrology. Past
and present RRT modalities such as PD or HF are often
seen as the domains of either the PICU or nephrology.
Other programs have developed a cooperative way to co-
manage patients adequately in order to ensure optimal
care. Although no data are available, logically, a cooper-
ative effort between the nephrologist and intensivist
would seem most likely to result in optimal patient care.
In order to provide support for modalities, such as HF, a
highly educated nursing staff is required. HF may be done
only occasionally due to the relative infrequency of pediat-
ric ARF requiring HF at many programs. If done intermit-
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Fig. 3 Survival by diagnosis and RRT: In the bone marrow trans-
plant (BMT) population, there was a greater survival rate in those
children who required only HD as compared to PD or HF (P<0.05
HD vs PD or HF), while in the sepsis patients, there was poorer
survival rate in those on HF as compared to PD or HD (P<0.05 HF
vs HD or PD). This finding was consistent in all causes of ARF
Fig. 4 Pressor use by diagnosis and RRT modality: In the BMT
and sepsis population less vasopressor use occurred in those re-
ceiving intermittent HD vs those on continuous HF or PD (P<0.01
HD vs PD or HF in both BMT and sepsis). This finding was con-
sistent in all causes of ARF
tently or seldomly, in some units, the expertise of nursing
staff may not be as well developed, therefore potentially
negatively impacting the outcome of patients. It is often in
the best interest of children to be transferred to a unit (ei-
ther within the hospital or perhaps to another hospital) that
has nursing expertise. Alternately, a mobile well-trained
nursing staff could travel to the child for HF [28].
Finally, through mutual cooperation between industry
and physicians, new equipment including access and pe-
diatric-specific HD and HF equipment has been devel-
oped and found to have had a positive impact on RRT.
There may still be specific difficulties for applications in
the smaller children; experience over time has proven
this newer equipment to be effective [29, 30].
Summary
The outcome of children requiring RRT appears to be di-
rectly related to their underlying diagnosis as well as
their requirements for pressor use. It is suggested that in
some children the choice of RRT may influence out-
come, yet no prospective randomized studies have been
conducted for children to date to look at this question.
Furthermore, attention to drug dosing, fluid manage-
ment, nutritional delivery and losses during RRT, as well
as overall medical care, is important in the care of chil-
dren requiring RRT. We believe this can best be done co-
operatively between skilled pediatric nephrologists and
critical care physicians in the care of these children.
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